Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brent Ferrell

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Leukemia Research|January 9, 2018
Genotypic and clinical heterogeneity within NCCN favorable-risk acute myeloid leukemiaStephen A Strickland, Aaron C Shaver, Michael Byrne, et al.
JCI Insight|November 19, 2020
Bone marrow Tregs mediate stromal cell function and support hematopoiesis via IL-10Virginia Camacho, Victoria R Matkins, Sweta B Patel, et al.
Cancer Immunology Research|November 11, 2018
Computational Immune Monitoring Reveals Abnormal Double-Negative T Cells Present across Human Tumor TypesAllison R Greenplate, Daniel D McClanahan, Brian K Oberholtzer, et al.
American Journal of Hematology|May 12, 2020
The use of venetoclax-based salvage therapy for post-hematopoietic cell transplantation relapse of acute myeloid leukemiaMichael Byrne, Nathalie Danielson, Salyka Sengsayadeth, et al.
Blood Cancer Journal|January 15, 2024
Driver mutation zygosity is a critical factor in predicting clonal hematopoiesis transformation riskAshwin Kishtagari, M A Wasay Khan, Yajing Li, et al.
Immunohorizons|December 22, 2022
Acly Deficiency Enhances Myelopoiesis through Acetyl Coenzyme A and Metabolic-Epigenetic Cross-TalkDalton L Greenwood, Haley E Ramsey, Phuong T T Nguyen, et al.
Journal of Hematology & Oncology|January 17, 2025
Olutasidenib in combination with azacitidine induces durable complete remissions in patients with relapsed or refractory mIDH1 acute myeloid leukemia: a multicohort open-label phase 1/2 trialJorge E Cortes, Gail J Roboz, Maria R Baer, et al.
Blood Advances|March 20, 2024
Multiomic profiling of human clonal hematopoiesis reveals genotype and cell-specific inflammatory pathway activationJ Brett Heimlich, Pawan Bhat, Alyssa C Parker, et al.
Targeted Oncology|July 29, 2021
Selective Inhibition of JAK1 Primes STAT5-Driven Human Leukemia Cells for ATRA-Induced DifferentiationHaley E Ramsey, Kristy Stengel, James C Pino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2025
Clonal Hematopoiesis of Indeterminate Potential Influences Breast Cancer Outcomes in a Genotype-Specific MannerSarah C Reed, Chad R Potts, Leo Y Luo, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Leukemia Research|January 9, 2018
Genotypic and clinical heterogeneity within NCCN favorable-risk acute myeloid leukemiaStephen A Strickland, Aaron C Shaver, Michael Byrne, et al.
JCI Insight|November 19, 2020
Bone marrow Tregs mediate stromal cell function and support hematopoiesis via IL-10Virginia Camacho, Victoria R Matkins, Sweta B Patel, et al.
Cancer Immunology Research|November 11, 2018
Computational Immune Monitoring Reveals Abnormal Double-Negative T Cells Present across Human Tumor TypesAllison R Greenplate, Daniel D McClanahan, Brian K Oberholtzer, et al.
American Journal of Hematology|May 12, 2020
The use of venetoclax-based salvage therapy for post-hematopoietic cell transplantation relapse of acute myeloid leukemiaMichael Byrne, Nathalie Danielson, Salyka Sengsayadeth, et al.
Blood Cancer Journal|January 15, 2024
Driver mutation zygosity is a critical factor in predicting clonal hematopoiesis transformation riskAshwin Kishtagari, M A Wasay Khan, Yajing Li, et al.
Immunohorizons|December 22, 2022
Acly Deficiency Enhances Myelopoiesis through Acetyl Coenzyme A and Metabolic-Epigenetic Cross-TalkDalton L Greenwood, Haley E Ramsey, Phuong T T Nguyen, et al.
Journal of Hematology & Oncology|January 17, 2025
Olutasidenib in combination with azacitidine induces durable complete remissions in patients with relapsed or refractory mIDH1 acute myeloid leukemia: a multicohort open-label phase 1/2 trialJorge E Cortes, Gail J Roboz, Maria R Baer, et al.
Blood Advances|March 20, 2024
Multiomic profiling of human clonal hematopoiesis reveals genotype and cell-specific inflammatory pathway activationJ Brett Heimlich, Pawan Bhat, Alyssa C Parker, et al.
Targeted Oncology|July 29, 2021
Selective Inhibition of JAK1 Primes STAT5-Driven Human Leukemia Cells for ATRA-Induced DifferentiationHaley E Ramsey, Kristy Stengel, James C Pino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2025
Clonal Hematopoiesis of Indeterminate Potential Influences Breast Cancer Outcomes in a Genotype-Specific MannerSarah C Reed, Chad R Potts, Leo Y Luo, et al.
Pageof 5